Pathogenic variants in the PNPLA6 gene have been originally described in patients presenting a neurological phenotype characterized by early-onset spastic paraplegia, motor neuropathy, and distal muscle wasting. This evidence concerns the gene PNPLA6 and Spastic paraplegia.